FORM 6-K

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549  

 

Report of Foreign Private Issuer 

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934 

 

For the month of May, 2020

Commission File Number: 001-38562

 

NEW FRONTIER HEALTH CORPORATION 
(Translation of Registrant’s Name into English)

 

10 Jiuxianqiao Road,
Hengtong Business Park
B7 Building, 1/F
Chaoyang District, 100015,
Beijing, China
(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F x Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes ¨ No x

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes ¨ No x

 

 

 

 

 

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

 

Attached as Exhibits 99.1 and 99.2 hereto are the earnings release issued by New Frontier Health Corporation (the “Company”) announcing its financial results for the first quarter ended March 31, 2020, and associated investor presentation, respectively.

 

EXHIBIT INDEX

 

 

Exhibit Description of Exhibit
99.1 Earnings Release.
99.2 Investor Presentation.

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  New Frontier Health Corporation
     
  By: /s/ Roberta Lipson
    Name: Roberta Lipson
    Title: Chief Executive Officer

 

Date: May 27, 2020

 

 

 

 

 

 

New Frontier Health (NYSE:NFH)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos New Frontier Health.
New Frontier Health (NYSE:NFH)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos New Frontier Health.